But his brain stubbornly remains at the anatomic age of 42. “The brain is really hard to rejuvenate,” he lamented on ...

MSD and partner Moderna have started a late-stage trial of their personalised cancer vaccine V940 as a combination with MSD’s PD-1 inhibitor Keytruda for patients with non-small cell lung cancer ...